Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the National Comprehensive ...
Early clinical proof-of-concept for WEE1 inhibitor APR-1051 in the ongoing ACESOT-1051 trial with two partial responders at first scan in endometrial cancer patients with PPP2R1A mutationClinical team ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
Long waits for tests, including MRI scans, CT scans, ultrasounds, endoscopies, and heart investigations, can delay treatment ...
Rising medical costs make critical illness insurance essential. Learn how a lump-sum payout protects your savings and family.
Hosted on MSN
A new playbook for assessing older patients with cancer in places where resources are scarce
A University of Colorado Cancer Center leader co-chaired an international expert panel that drafted new global guidelines for conducting geriatric assessments of older people with cancer in parts of ...
Multi-cancer blood tests promise early detection, but the evidence is thin, the risks real, and they’re no substitute for listening to your body.
A recent study by Fred Hutch biochemist Christopher Lapointe, PhD, and his colleagues, uses innovative lab techniques to ...
HUTCHMED divested a 45.0% equity interest in SHPL for $608.5 million in cash in April 2025, retaining a 5.0% equity interest. As a result, HUTCHMED’s share of equity in earnings of SHPL in 2025 ...
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...
Department of Homeland Security Sec. Kristi Noem gave surprising testimony on Tuesday, claiming she did not know basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results